Skip to content

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03391180
Enrollment
120
Registered
2018-01-05
Start date
2018-02-28
Completion date
2018-07-31
Last updated
2018-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

White Spot Lesion

Brief summary

The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.

Detailed description

The participants were categorized to either group (group1) receiving ICON treatment method (Icon, DMG, Germany), or (group 2) who shall be receiving CPP-ACPF treatment method (Tooth Mousse plus).

Interventions

DRUGICON Remineralization

A material used for the Remineralization of white spot lesions.

Casein phosphopeptide-Amorphous calcium phosphate fluoride used for the remineralization of white spot lesions.

Sponsors

Riyadh Colleges of Dentistry and Pharmacy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* permanent dentition, in good general health and without systemic diseases, who had received fixed orthodontic treatment.

Exclusion criteria

* Patients with primary dentition, enamel hypoplasia, dental fluorosis or tetracycline pigmentation and carious cavity were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Remineralization3 MonthsUsing DIAGNOdent Laser device.

Countries

Saudi Arabia

Contacts

Primary ContactOmar H AlKadhi, BDS, MS
omar.alkadhi@riyadh.edu.sa966505154754
Backup ContactLougin K Brekeit, BDS
lougin.bk@gmail.com966556461314

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026